Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 327

Similar articles for PubMed (Select 11793381)

1.

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine.

Heijtink RA, Kruining J, van Bergen P, de Rave S, van Hattum J, Schutten M, Osterhaus AD.

J Med Virol. 2002 Mar;66(3):304-11.

PMID:
11793381
2.

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.

Heijtink RA, van Bergen P, van Roosmalen MH, Sünnen CM, Paulij WP, Schalm SW, Osterhaus AD.

Vaccine. 2001 Jun 14;19(27):3671-80.

PMID:
11395201
4.

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.

Heijtink RA, van Bergen P, Paulij WP, de Man RA, Osterhaus AD.

Vaccine. 2000 Feb 14;18(15):1531-8.

PMID:
10618551
5.

Immunological properties of recombinant HBsAg produced in yeast.

Hauser P, Voet P, Simoen E, Thomas HC, Pêtre J, De Wilde M, Stephenne J.

Postgrad Med J. 1987;63 Suppl 2:83-91.

PMID:
2446304
6.

Quantitation of group-specific a antigen in hepatitis B vaccines by anti-HBs/a monoclonal antibody.

Yamamoto H, Satoh T, Kiyohara T, Totsuka A, Moritsugu Y.

Biologicals. 1997 Dec;25(4):373-80.

PMID:
9467033
7.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
8.

Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.

Jafarzadeh A, Montazerifar SJ.

J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):4-9.

PMID:
17591001
9.

Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.

Ambrosch F, Frisch-Niggemeyer W, Kremsner P, Kunz C, André F, Safary A, Wiedermann G.

Postgrad Med J. 1987;63 Suppl 2:129-35.

PMID:
3317348
10.

Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.

Zheng X, Weinberger KM, Gehrke R, Isogawa M, Hilken G, Kemper T, Xu Y, Yang D, Jilg W, Roggendorf M, Lu M.

Virology. 2004 Nov 24;329(2):454-64.

11.

[Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].

Liang Z, Li C, Jing Q.

Zhonghua Yu Fang Yi Xue Za Zhi. 1998 May;32(3):165-7. Chinese.

PMID:
10322792
12.

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination.

Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, Twu SJ, Su IJ, Huang LM, Lee CY.

Hepatology. 2004 Dec;40(6):1415-20.

PMID:
15565627
13.

Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine.

Odinsen O, Owusu-Ofori S, Dompreh A, Sarkodie F, Opare-Sem O, Parker D, Allain JP.

Clin Vaccine Immunol. 2007 Dec;14(12):1623-8. Epub 2007 Oct 10.

14.

Properties of recombinant hepatitis B vaccine.

Ohmura T, Ohmizu A, Sumi A, Ohtani W, Uemura Y, Arimura H, Nishida M, Kohama Y, Okabe M, Mimura T, et al.

Biochem Biophys Res Commun. 1987 Dec 31;149(3):1172-8.

PMID:
2962578
15.

Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring "a" loop escape mutations.

Cooreman MP, van Roosmalen MH, te Morsche R, Sünnen CM, de Ven EM, Jansen JB, Tytgat GN, de Wit PL, Paulij WP.

Hepatology. 1999 Nov;30(5):1287-92.

PMID:
10534351
16.

Long-term persistence of T cell memory to HBsAg after hepatitis B vaccination.

Wang RX, Boland GJ, van Hattum J, de Gast GC.

World J Gastroenterol. 2004 Jan 15;10(2):260-3.

17.

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A; Study Group.

Lancet. 2005 Oct 15-21;366(9494):1379-84.

PMID:
16226616
18.
19.

Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination.

Sam MR, Shokrgozar MA, Shokri F.

Intervirology. 2008;51(2):87-95. doi: 10.1159/000131666. Epub 2008 May 13.

PMID:
18477849
20.

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.

Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN.

Vaccine. 2009 Mar 13;27(12):1858-62. doi: 10.1016/j.vaccine.2009.01.027. Epub 2009 Jan 30.

PMID:
19186203
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk